Lipidomic analysis of brain tissues and plasma in a mouse model expressing mutated human amyloid precursor protein/tau for Alzheimer's disease. - Wikidata - awgldk - TriplyDB

Lipidomic analysis of brain tissues and plasma in a mouse model expressing mutated human amyloid precursor protein/tau for Alzheimer's disease.

Lipidomic analysis of brain tissues and plasma in a mouse model expressing mutated human amyloid precursor protein/tau for Alzheimer's disease.

http://www.wikidata.org/entity/Q36888838

about

Sphingolipids and Epoxidized Lipid Metabolites in the Control of Gut Immunosurveillance and Allergy Measuring brain lipids ACAT1/SOAT1 as a therapeutic target for Alzheimer's disease Effects of sex, age, and fasting conditions on plasma lipidomic profiles of fasted Sprague-Dawley rats Genome-wide analysis of Saccharomyces cerevisiae identifies cellular processes affecting intracellular aggregation of Alzheimer's amyloid-β42: importance of lipid homeostasis.Serum metabolomic biomarkers of dementia The 12/15-lipoxygenase as an emerging therapeutic target for Alzheimer's disease Impact of acamprosate on plasma amyloid-β precursor protein in youth: a pilot analysis in fragile X syndrome-associated and idiopathic autism spectrum disorder suggests a pharmacodynamic protein marker.Glucosylceramide and lysophosphatidylcholines as potential blood biomarkers for drug-induced hepatic phospholipidosis.Mass Spectrometry-based Lipidomics and Its Application to Biomedical Research Acyl-coenzyme A:cholesterol acyltransferase 1 blockage enhances autophagy in the neurons of triple transgenic Alzheimer's disease mouse and reduces human P301L-tau content at the presymptomatic stage.Dietary ω3 fatty acid exerts anti-allergic effect through the conversion to 17,18-epoxyeicosatetraenoic acid in the gut.Characterization of hepatic lipid profiles in a mouse model with nonalcoholic steatohepatitis and subsequent fibrosis The ratio of phosphatidylcholines to lysophosphatidylcholines in plasma differentiates healthy controls from patients with Alzheimer's disease and mild cognitive impairment 12-HETER1/GPR31, a high-affinity 12(S)-hydroxyeicosatetraenoic acid receptor, is significantly up-regulated in prostate cancer and plays a critical role in prostate cancer progression.Lipidomic Signatures and Associated Transcriptomic Profiles of Clear Cell Renal Cell Carcinoma Plasma lipidome is independently associated with variability in metabolic syndrome in Mexican American families.P450 Eicosanoids and Reactive Oxygen Species Interplay in Brain Injury and Neuroprotection.Cellular Cholesterol Homeostasis in Alzheimer's Disease.Novel "omics" approach for study of low-abundance, low-molecular-weight components of a complex biological tissue: regional differences between chorionic and basal plates of the human placenta.Comprehensive identification of age-related lipidome changes in rat amygdala during normal aging From peroxisomal disorders to common neurodegenerative diseases - the role of ether phospholipids in the nervous system.Plasma lipids metabolism in mild cognitive impairment and Alzheimer's disease.Dioxin-induced increase in leukotriene B4 biosynthesis through the aryl hydrocarbon receptor and its relevance to hepatotoxicity owing to neutrophil infiltration.Analysis of eicosanoid oxidation products in Alzheimer brain by LC-MS with uniformly 13C-labeled internal standards.

P2860

Q26767382-4A9151DF-21F5-4C61-AAC9-FB3BE4787CE1 Q26825113-6D3B53B9-697B-4833-B50F-762FA1B34ECD Q28081654-49DF2558-39CF-4B9B-8D12-47F47207C7FF Q28397262-FD855BD7-E21B-4B95-A123-2F3409D05EF3 Q33975871-1DFF44E6-BC16-4BA5-B7F5-16351CEF4B80 Q34042727-5FB08D5A-BB0F-495C-B52F-D823BB4947F1 Q34464174-3A18FB89-9AE8-4E9B-9EA0-A5C22338B8FE Q34620558-3F43CD64-5C2D-4754-BFB4-528E7321C6E2 Q34736225-8DC06BD9-DCB7-4F22-843B-6871A4C9002B Q35332947-576D3BE7-4105-4A71-8F0F-D5724EFD28C7 Q35688942-BAE40330-4579-4819-A062-8AF316857342 Q35727514-48EA3BD2-A36E-41E4-9587-206FAA1EA1F4 Q35972941-7ED717D3-FF17-48AA-98B9-1DFF75D2E9A4 Q36428387-C91D0C5D-EF04-4853-8577-A619C707A4DE Q36913759-A905732A-E81F-4756-818E-630F583DCD0C Q37054261-3D6B1A35-5573-4EFD-B4A7-9208209C341F Q37716371-0FA96628-38E2-4A8E-8131-82FA1C7E67CD Q38744600-48828F50-F6D2-49F1-BC81-80003279FEE7 Q39180626-886761A3-D021-4DF8-A9B4-45D72F9D6201 Q40561932-4C88D770-512C-44EC-8275-C0165A4A9C76 Q41739566-3E5F98DB-BCDC-4B97-B8F6-B465661126E6 Q48159157-D369ED5A-4972-457A-945B-989168E0AEAD Q50041775-5B4AEABE-357B-4984-8B6B-935FA84D49D7 Q51012045-56BD8A1D-6F6F-4D8A-808B-5AF3B6F0157C Q52373518-7DAAC43F-CCC1-4AE2-9FC2-5F2666F32030

P2860

Lipidomic analysis of brain tissues and plasma in a mouse model expressing mutated human amyloid precursor protein/tau for Alzheimer's disease.

http://www.wikidata.org/entity/Q36888838

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Lipidomic analysis of brain ti ...... n/tau for Alzheimer's disease.

@en

type

label

Lipidomic analysis of brain ti ...... n/tau for Alzheimer's disease.

@en

prefLabel

Lipidomic analysis of brain ti ...... n/tau for Alzheimer's disease.

@en

P1433

Q36888838-82CE6499-505D-4FEB-8CB3-A45B5CE4013E

P1476

Q36888838-A2D0DA3F-10DD-48F9-86A8-B9DE09464919

P2093

Q36888838-0C3FC9CC-C205-4627-B33C-CD695439F520

Q36888838-37B7CAFB-29E9-4263-B507-DD99D1D467BA

Q36888838-402B8F6C-249A-4478-9F46-C522AD0BFE9E

Q36888838-52B6A0D2-418F-4BB9-BD71-45EB19F57525

Q36888838-5FBE90DA-9458-4D18-AACD-169A990898E7

Q36888838-68EFB8E0-F9A6-4431-A4F7-24F872D8D195

Q36888838-85CC64F8-59EE-484A-89E7-6CE866F23794

Q36888838-8695113B-DB80-4090-AD16-DA282A2F2BEC

Q36888838-94CD2695-4FA5-457A-AB60-B3B70FE1B75A

Q36888838-99F3C60A-55BA-462D-BEC8-11E6C8D0F5CE

P2860

Q36888838-0303C436-998D-47BC-8C50-1F6F0D2B71C0

Q36888838-0532387E-5A63-4EB3-A4E6-CE6FF86F081D

Q36888838-06A1EA7A-D915-426E-A7CC-E0A4CE08A2E2

Q36888838-0D16B42F-8C7C-4D8F-BB26-8E15069082A9

Q36888838-15BD32D4-196E-4A06-AA9B-C34FE1401314

Q36888838-1A7F85C3-4825-44B0-BFC1-80A501B30F9F

Q36888838-28505B39-590B-4F86-BD03-6574D57337A1

Q36888838-35B900D9-0B98-461B-BE70-2872FD935E17

Q36888838-3A0A9A08-54C5-4790-A07A-EE695CD9595C

Q36888838-55608FEE-F7E9-43BD-BC29-2882A927F940

P2888

Q36888838-08E4413C-09CB-41AE-A4BC-A783CD915E1A

P304

Q36888838-13AB7B61-B42C-4AD9-A604-35C73A36D9A0

P31

Q36888838-BF352DD4-AC4F-4E35-A8DD-4BA275483D9B

P356

Q36888838-53A5048F-920B-4F18-BE50-B36849C36519

P478

Q36888838-B907E8A7-D1E7-4770-8E0E-9D5CDD0C7DF7

P577

Q36888838-C423370C-2CE7-4448-BB8E-B61C2B00772B

P6179

Q36888838-BA9729A7-A725-45E1-B9D0-A445A2AC5548

P698

Q36888838-75AEBD18-D602-4A73-A440-5512B67E6E84

P921

Q36888838-054DA1BE-CAFE-44E2-948D-4DF6F2A1DB4C

P932

Q36888838-0922546D-E4FD-4EA2-8509-CA218A7C548C

P356

1476-511X-12-68

P1433

Lipids in Health and Disease

P1476

Lipidomic analysis of brain ti ...... n/tau for Alzheimer's disease.

@en

P2093

Alato Okuno

http://www.w3.org/2001/XMLSchema#string

Hiroki Nakanishi

http://www.w3.org/2001/XMLSchema#string

Kazutaka Ikeda

http://www.w3.org/2001/XMLSchema#string

Keiko Maekawa

http://www.w3.org/2001/XMLSchema#string

Makoto Arita

http://www.w3.org/2001/XMLSchema#string

Masaki Ishikawa

http://www.w3.org/2001/XMLSchema#string

Mayumi Murayama

http://www.w3.org/2001/XMLSchema#string

Osamu Takikawa

http://www.w3.org/2001/XMLSchema#string

Ryo Taguchi

http://www.w3.org/2001/XMLSchema#string

Ryuta Mikawa

http://www.w3.org/2001/XMLSchema#string

P2860

Metabolomics in early Alzheimer's disease: identification of altered plasma sphingolipidome using shotgun lipidomics

12/15-lipoxygenase is increased in Alzheimer's disease: possible involvement in brain oxidative stress

A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease.

A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION

Epoxyeicosanoid signaling in CNS function and disease

Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective

Label-free quantitative proteomics using large peptide data sets generated by nanoflow liquid chromatography and mass spectrometry.

15S-Hydroxyeicosatetraenoic acid activates peroxisome proliferator-activated receptor gamma and inhibits proliferation in PC3 prostate carcinoma cells.

Identification and characterisation of soluble epoxide hydrolase in mouse brain by a robust protein biochemical method.

Plasmalogen deficiency in early Alzheimer's disease subjects and in animal models: molecular characterization using electrospray ionization mass spectrometry.

P2888

1476-511x-12-68

P304

68

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1476-511X-12-68

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P577

2013-05-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1018057328

http://www.w3.org/2001/XMLSchema#string

P698

23659495

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

3668217

http://www.w3.org/2001/XMLSchema#string